OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
SPHRY
Starpharma Holdings Ltd.
Sponsored ADR (1 ADS : 10 Ordinary)
N/A
N/A
N/A
Market Cap calculated only for this class of securities.
24,181,757
Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Starpharma Holdings Limited (ASX: SPL, US OTC: SPHRY) is an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient. Our mission is to help patients with significant illnesses, such as cancer, achieve improved health outcomes and quality of life through the application of our unique dendrimer technology.
Videos
Joined OTCQX 03/2007
Securities
Other Starpharma Holdings Ltd. Securities
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
Last
N/A
Change
N/A (N/A)
Bid
N/A
Ask
N/A
Volume
Time
